Wockhardt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WOCKHARDT, and what generic and branded alternatives to WOCKHARDT drugs are available?
WOCKHARDT has one hundred and three approved drugs.
There are three tentative approvals on WOCKHARDT drugs.
Summary for Wockhardt
US Patents: | 0 |
Tradenames: | 81 |
Ingredients: | 74 |
NDAs: | 103 |
Patent Litigation for Wockhardt: | See patent lawsuits for Wockhardt |
PTAB Cases with Wockhardt as petitioner: | See PTAB cases with Wockhardt as petitioner |
Drugs and US Patents for Wockhardt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wockhardt Bio Ag | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 202498-005 | Jan 4, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Wockhardt Ltd | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 077677-002 | Mar 16, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Wockhardt | BUTABARBITAL SODIUM | butabarbital sodium | ELIXIR;ORAL | 085383-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.